JP2010530001A5 - - Google Patents

Download PDF

Info

Publication number
JP2010530001A5
JP2010530001A5 JP2010512395A JP2010512395A JP2010530001A5 JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5 JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010512395 A JP2010512395 A JP 2010512395A JP 2010530001 A5 JP2010530001 A5 JP 2010530001A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
sulfide
blood flow
nitric oxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010512395A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010530001A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/066973 external-priority patent/WO2008157393A1/en
Publication of JP2010530001A publication Critical patent/JP2010530001A/ja
Publication of JP2010530001A5 publication Critical patent/JP2010530001A5/ja
Pending legal-status Critical Current

Links

JP2010512395A 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用 Pending JP2010530001A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94444407P 2007-06-15 2007-06-15
PCT/US2008/066973 WO2008157393A1 (en) 2007-06-15 2008-06-13 Compositions comprising sulfide alone or in combination with nitric oxide and their use to

Publications (2)

Publication Number Publication Date
JP2010530001A JP2010530001A (ja) 2010-09-02
JP2010530001A5 true JP2010530001A5 (enExample) 2011-07-28

Family

ID=39670390

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010512395A Pending JP2010530001A (ja) 2007-06-15 2008-06-13 硫化物単独または一酸化窒素との組み合わせを含む組成物およびその使用

Country Status (4)

Country Link
US (3) US20100247680A1 (enExample)
EP (1) EP2155213A1 (enExample)
JP (1) JP2010530001A (enExample)
WO (1) WO2008157393A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2605631A1 (en) * 2005-04-20 2006-10-26 Fred Hutchinson Cancer Research Center Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms
JP5274248B2 (ja) 2005-05-27 2013-08-28 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 酸化窒素治療及び医生物的応用のための酸化窒素放出粒子
US7923037B2 (en) 2006-10-05 2011-04-12 Ikaria, Inc. Liquid chalcogenide compositions and methods of manufacturing and using the same
US20100183748A1 (en) * 2009-01-21 2010-07-22 Ikaria, Inc. Methods for Treating or Preventing Radiocontrast Agent Induced Kidney Injury
US8541396B2 (en) 2009-04-24 2013-09-24 National University Of Singapore Morpholin-4-ium 4 methoxyphenyl (morpholino) phosphinodithioate (GYY4137) as a novel vasodilator agent
CN105214193B (zh) * 2009-05-27 2017-11-17 马林克罗特医疗产品知识产权公司 用于药物递送调节装置的分度药物收容装置组件及分度药物递送系统
DK2467173T3 (da) 2009-08-21 2019-07-29 Novan Inc Sårbandager, fremgangsmåder til anvendelse heraf og fremgangsmåder til dannelse deraf
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
MX386702B (es) 2014-02-10 2025-03-19 Fred Hutchinson Cancer Center Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
AU2018322317B2 (en) 2017-08-25 2023-11-23 Mallinckrodt Pharmaceuticals Ireland Limited Methods to improve organ viability
TWI650326B (zh) 2017-10-24 2019-02-11 國立交通大學 醫藥組合物、化合物的用途及合成方法
JP6618976B2 (ja) * 2017-11-14 2019-12-11 イノ セラピューティクス エルエルシー 指標付弁と襟部を有する加圧容器組立体を係合するため、かつ薬物送達を調整するための装置と流体連通したプランジャ組立体により直線的に作動させるための装置および方法
EP3991737A4 (en) * 2019-06-28 2023-08-09 Sumitomo Seika Chemicals Co., Ltd. GAS COMPOSITION FOR USE IN WOUND TREATMENT, AND WOUND TREATMENT DEVICE
CN111228223B (zh) * 2020-03-06 2021-06-18 同济大学 一种促进伤口愈合的聚合物囊泡及其制备方法和应用
CN114099419B (zh) * 2021-11-19 2023-03-24 苏州大学 一种载硫氢化钠可注射纳米纤维化水凝胶及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69614024T2 (de) * 1995-04-20 2001-11-15 Clariant Finance (Bvi) Ltd., Tortola Stabile flüssige Schwefelfarbstoffsuspensionen und Verfahren zu deren Analyse
CA2430415A1 (en) * 2000-12-15 2002-06-20 Galileo Laboratories, Inc. Use of tocopherol, metabolites or derivatives thereof or flavonoid metabolites or derivatives thereof in the manufacture of a medicament for the treatment of tissue ischemia
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
PL375161A1 (en) * 2002-06-21 2005-11-28 University Of Pittsburgh Of The Commonwealth System Of Higher Education Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
US20050136125A1 (en) * 2003-10-22 2005-06-23 Roth Mark B. Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms
CA2646674A1 (en) * 2006-04-20 2007-11-01 Fred Hutchinson Cancer Research Center Use of chalcogenides for treating shock and other adverse conditions
MX2009003741A (es) * 2006-10-05 2009-07-10 Ikaria Inc Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.
US20100143503A1 (en) * 2006-12-22 2010-06-10 Ikaria, Inc. Combinations of nitric oxide and sulfide and methods of use and manufacture thereof

Similar Documents

Publication Publication Date Title
JP2010530001A5 (enExample)
JP2014515028A5 (enExample)
MX2013001749A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
JP2007277274A5 (enExample)
WO2014188279A3 (en) Apparatus for delivering devices for reducing left atrial pressure
JP2008545715A5 (enExample)
JP2011057709A5 (enExample)
JP2014139255A5 (enExample)
JP2011503212A5 (enExample)
JP2008545703A5 (enExample)
El-Tahan Preoperative ephedrine counters hypotension with propofol anesthesia during valve surgery: a dose dependent study
EA201070084A1 (ru) Новое применение известных фармакологически активных химических соединений
EA201071138A1 (ru) Применение дронедарона для получения лекарственного средства для лечения пациентов с аритмией и с повышенным уровнем креатинина в результате введения дронедарона
JP2010526884A5 (enExample)
CN103340863A (zh) 烟酰胺在制备治疗糖尿病伤口愈合药物中的应用
HRP20200897T1 (hr) Parenteralna formulacija esmolola
RU2004121780A (ru) Способ лечения
Oudemans-van Straaten Strategies to prevent contrast nephropathy
Ahmed et al. Anesthetic management of a patient with hypertrophic obstructive cardiomyopathy undergoing modified radical mastectomy
Shaff et al. Anesthetic management for transurethral resection of the bladder in a 74-year-old man with uncorrected tetralogy of Fallot
JP2007523111A5 (enExample)
Kang et al. Effect of prophylactic continuous infusion of isosorbide dinitrate on myocardial protection and hemodynamics in patients undergoing off-pump coronary bypass surgery
Research et al. Periodontal management of patients with cardiovascular diseases
CN202843855U (zh) 一种新型冠状动脉血管支架
Leech et al. Unstable wide complex tachycardia: Consider hyperkalemia while preparing for cardioversion